<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Previous studies revealed that Guizhi-Fuling-Capsules (GZFLC), a traditional Chinese medical (Kampo) formulation composed of five kinds of medicinal plants, Cinnamomum cassia BLUME (Cinnamomi Cortex), Paeonia lactiflora PALL </plain></SENT>
<SENT sid="1" pm="."><plain>(Peonies Radix), Paeonia suffruticosa ANDREWS (Moutan Cortex), Prunus persica BATSCH (Persicae Semen), and Poria cocos WOLF (Hoelen), exerts a protective effect against vascular injury and has a protective effect against <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>- or <z:chebi fb="13" ids="29785">nitro</z:chebi> <z:chebi fb="177" ids="25741,29356">oxide</z:chebi>-mediated neuronal damage </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, the effect of GZFLC in a rat in vivo model of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and reperfusion was investigated </plain></SENT>
<SENT sid="3" pm="."><plain>Administration of GZFLC (0.3 and 0.9 g/kg, p.o.) after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> significantly decreased <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and water contents in rats subjected to 2-h <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> followed by 24-h reperfusion from 31.72 +/- 2.49%, 84.76 +/- 1.63% in the model group to 17.31 +/- 3.66%, 82.51 +/- 1.36% and 8.30 +/- 3.73%, 81.35 +/- 1.73%, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, analysis of inflammatory cytokines in ischemic brain showed that GZFLC treatment significantly down-regulated expressions of pro-inflammatory cytokines including interleukin (IL)-1beta and tissue <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha and markedly up-regulated expressions of anti-inflammatory cytokines IL-10 and IL-10R both in <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein levels </plain></SENT>
<SENT sid="5" pm="."><plain>The serum levels of these inflammatory cytokines were also regulated the same way </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggested that GZFLC may be beneficial for the treatment of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>-reperfusion injury partly due to its anti-inflammatory properties </plain></SENT>
</text></document>